Monday, March 25, 2019

GSK reports positive data for experimental blood cancer drug

GlaxoSmithKline received a boost for its oncology research on Thursday, as it reported further positive data from a study of its experimental drug for blood cancer.


from Reuters: Health https://ift.tt/2JwqWrb

No comments: